Evidence map›Paper›PMID 31010812›Full record

ArticleInfection and immunity2019

CD4

Rekha R Rapaka, Guixiang Dai, Mingquan Zheng, Jay K Kolls

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Targeting β-glucans, vital components of theFrontiers in immunology · 2023
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Rekha R RapakaUniversity of Maryland Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA rrapaka@som.umaryland.edu.
Guixiang DaiCenter for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Mingquan ZhengCenter for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Jay K KollsCenter for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Tulane University · USUniversity of Maryland, Baltimore · US

Funding

Training in CD4 T-cell Lung ImmunityR35HL139930 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI KOLLS, JAY K · 2018 to 2024
$6.3M
Improved Therapeutics and Diagnostics for PneumocystisPneumoniaR01AI120033 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JAY K KOLLS · 2016 to 2026
$4.8M
Determinants of antibody-based host resistance against Pneumocystis cariniiF30ES015413 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI RAPAKA, REKHA R · 2006 to 2009
$157k
NHLBI NIH HHS R35 HL139930NIAID NIH HHS R01 AI120033NIEHS NIH HHS F30 ES015413
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Animalsbeta-GlucansCD4-Positive T-LymphocytesCell WallChitinChitosanCross ReactionsImmunoglobulin GLungLymphocyte DepletionMice, Inbred BALB CPneumocystisPneumonia, PneumocystisT-Lymphocytes, Regulatorybeta-GlucansChitinChitosanImmunoglobulin Gantibodybeta glucanCD4 T cellchitininfectious diseasemucosal immunityopportunistic fungiPneumocystis

Identifiers

PMID31010812
PMCPMC6589063
OpenAlexW2936941284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.